Following the indictment by the panel, Haryana Health minister Anil Vij said an FIR will be lodged against the private hospital while the license of its blood bank will be cancelled.
In addition, the Haryana Urban Development Authority (HUDA) will be asked to explore the possibilities for cancellation of lease of land given to the hospital, he said.
"The hospital made a hefty profit on medicines given, which works out to 108 per cent, and for some consumables it is as high as 1737 per cent," he alleged, pointing out that the bill for Adya Singh's treatment shot upto Rs 15 lakh.
The Fortis group, meanwhile, said that all documents, statements and details required by the probe team of the Haryana government were provided. A statement released by the group added that they were "yet to receive a copy of the report".
At the press conference, Vij, flanked by the probe committee members, claimed there were many irregularities, unethical practices and protocol of diagnosis and medical duties was not adopted.
"The death of the girl has happened due to Leave Against Medical Advice (LAMA) protocol not being followed. The girl was on a ventilator, but she was put in an ordinary ambulance, ventilator was withdrawn and an ambu bag was not provided in that, which became the cause of her death, which is a very serious irregularity," Vij said.
"Negligence, lapse, unethical, unlawful acts on the part of the team of doctors of Fortis hospital has been found when the patient was shifted from the ICU to the ambulance," he alleged.
The Minister further said that his department will write to the Medical Council of India demanding action against the hospital.
As far as this death due to negligence goes, we are going to register a FIR against the Fortis hospital because the child's death has occurred due to negligence, he said.
A committee headed by Dr Rajiv Wadhera, Additional DG, Health, Haryana, which submitted its report today, was set up by Haryana government on November 21 to probe allegations that the private hospital overcharged the girl's family.
The hospital had earlier refuted the charges, claiming the patient's family was informed about the bill on a daily basis and that there was no medical negligence.
Vij said the girl's parents also put their views before the committee. He said she was diagnosed with dengue and admitted to Rockland hospital in Delhi's Dwarka.
"Later on the patient was diagnosed as suffering from Dengue Shock Syndrome. She was admitted to Fortis, Gurgaon on August 31," he said.
Vij said that legal opinion will be sought on filing an FIR. "But we have decided that we will lodge FIR against this Fortis hospital for medical negligence," he said.
He said dengue is a notifiable disease "but it was not notified by the FMRI to the local authorities, which is a lapse". Our CMO has given them notice for this, he said.
He claimed that costly medicines were used when cheaper substitutes were available.
A costly injection was administered on most occasions, which cost Rs 3,112 whereas a substitute costing Rs 499 was available, Vij claimed.
"The hospital made a hefty profit on medicines given, which works out to 108 per cent, and for some consumables it is as high as 1737 per cent," he said citing the report.
"We are writing to HUDA in this regard because they have violated MoU agreements and if lease has to be cancelled, the HUDA committee will look into it," he said.
Vij also claimed that the girl's family had alleged that their signatures were forged on some of the consent forms.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
